Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"ClinicalTrials.gov"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22SARS-CoV2%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22SARS-CoV2%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22SARS-CoV2%22&type=Subject
PubPharm (92)
1
Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection : A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of AXA1125 in Subjects With Fatigue-Predominant Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients : A Randomized Controlled Adaptive Study Comparing COVID-19 Convalescent Plasma (CCP) to Non-immune Plasma to Limit Coronavirus-associated Complications in Hospitalized Patients
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise : Phase 2, Randomized, Double-Blind Placebo Controlled Study of Intravenous Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Mouth Rinses for Inactivation of COVID-19 : Antiviral Efficacy and Acceptability of Therapeutic Antiseptic Mouth Rinses for Inactivation of COVID SARS-2 Virus
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection : A Prospective, Controlled, Randomized, Multicenter Study of the Efficacy of an Autophagy Inhibitor (GNS561), an Anti-NKG2A (Monalizumab) and an Anti-C5aR (Avdoralimab) Compared to the Standard of Care in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 (COVID-19) Infection.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 : A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects : A Phase II, Open-label, Rollover Trial to Evaluate the Safety and Immunogenicity of One or Two Boosting Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 Trial Subjects, or Two Boosting Doses of Comirnaty in BNT162-04 Trial Subjects
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years : A Randomized, Double-blind Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E-1 (Alpha/Beta/Delta/Omicron (BA.1/BA.4/BA.5) Variants S-Trimer COVID-19 Vaccine) in Population Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury : A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Safety and Efficacy of DUR-928 in Subjects Infected With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2) : A Virtual Phase 2 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Post-exposure Prophylaxis (PEP) for Newly-infected COVID-19 Patients
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
Nächster »
[10]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Filter aufheben
Thema: Phase: Phase 2
Medienart
92
Aufsätze
92
E-Artikel
92
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
92
610
Phase: Phase 2
92
Study Type: Interventional
40
COVID-19
33
Recruitment Status: Completed
20
Coronavirus Infections
17
Recruitment Status: Terminated
15
Communicable Diseases
15
Infections
15
Recruitment Status: Not yet recruiting
14
Pneumonia
12
Recruitment Status: Withdrawn
10
Infection
10
Recruitment Status: Recruiting
6
Medical Condition: COVID-19, SARS-CoV-2 Infection
6
Medical Condition: SARS-CoV-2
6
Medical Condition: SARS-CoV-2 Infection
6
Respiratory Insufficiency
5
Medical Condition: COVID-19, SARS-CoV-2
5
Pneumonia, Viral
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
36
2022
36
2021
20
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
92
Englisch
Haven't found what you're looking for?
Wird geladen...